Literature DB >> 16778134

Novel effect of oxidized low-density lipoprotein: cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase.

Sergiy Sukhanov1, Yusuke Higashi, Shaw-Yung Shai, Hiroyuki Itabe, Koichi Ono, Sampath Parthasarathy, Patrick Delafontaine.   

Abstract

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a classical glycolytic enzyme that is involved in cellular energy production and has important housekeeping functions. We used the natural prooxidant and proatherogenic molecule oxidized low-density lipoprotein (OxLDL) to determine a potential link between OxLDL-promoted oxidative stress, GAPDH expression, and smooth muscle cell energy metabolism. OxLDL but not native LDL (nLDL) produced a 60% to 100% dose- and time-dependent reduction of GAPDH protein. OxLDL increased reactive oxygen species (ROS) formation, including rapid elevation of H2O2 levels. OxLDL decreased intracellular catalase expression, likely contributing to the increase in H2O2. Antioxidants, anti-CD36 receptor antibody, NADPH oxidase, or lipoxygenase blockers decreased OxLDL-specific ROS and prevented GAPDH downregulation. 12/15-Lipoxygenase or p47phox deficiency resulted in attenuation of GAPDH downregulation, but 5-lipoxygenase suppression had no effect. OxLDL or exogenous H2O2 oxidized GAPDH thiols, decreasing GAPDH protein half-life and increasing GAPDH sensitivity to proteasome-mediated protein degradation in vitro. OxLDL- or small interfering RNA-specific downregulation of GAPDH resulted in 65% reduction in glycolysis rate and 82% decrease in ATP levels. In conclusion, our data demonstrate that OxLDL downregulated GAPDH via a H2O2-dependent decrease in protein stability. GAPDH protein damage resulted in marked depletion of cellular ATP levels. Our data have important implications for understanding the metabolic effect of OxLDL on the vessel wall and mechanism of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778134     DOI: 10.1161/01.RES.0000232319.02303.8c

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/apyrimidinic endonuclease I protect smooth muscle cells against oxidant-induced cell death.

Authors:  Xuwei Hou; Patricia Snarski; Yusuke Higashi; Tadashi Yoshida; Alexander Jurkevich; Patrick Delafontaine; Sergiy Sukhanov
Journal:  FASEB J       Date:  2017-04-12       Impact factor: 5.191

2.  CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.

Authors:  Wei Li; Maria Febbraio; Sekhar P Reddy; Dae-Yeul Yu; Masayuki Yamamoto; Roy L Silverstein
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

3.  Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability.

Authors:  Shaw-Yung Shai; Sergiy Sukhanov; Yusuke Higashi; Charlotte Vaughn; James Kelly; Patrice Delafontaine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07-29       Impact factor: 8.311

4.  Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes.

Authors:  Chandler A Long; Valy Boulom; Hassan Albadawi; Shirling Tsai; Hyung-Jin Yoo; Rahmi Oklu; Mitchell H Goldman; Michael T Watkins
Journal:  Ann Surg       Date:  2013-12       Impact factor: 12.969

5.  Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Shaw-Yung Shai; Svitlana Danchuk; Richard Tang; Patricia Snarski; Zhaohui Li; Patricia Lobelle-Rich; Meifang Wang; Derek Wang; Hong Yu; Ronald Korthuis; Patrice Delafontaine
Journal:  Circulation       Date:  2016-05-06       Impact factor: 29.690

Review 6.  IGF-1, oxidative stress and atheroprotection.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  Trends Endocrinol Metab       Date:  2010-01-12       Impact factor: 12.015

7.  Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody.

Authors:  Caroline Camaré; Magali Trayssac; Barbara Garmy-Susini; Elodie Mucher; Roger Sabbadini; Robert Salvayre; Anne Negre-Salvayre
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

8.  Mechanical properties of the extracellular matrix alter expression of smooth muscle protein LPP and its partner palladin; relationship to early atherosclerosis and vascular injury.

Authors:  Li Jin; Nicole E Hastings; Brett R Blackman; Avril V Somlyo
Journal:  J Muscle Res Cell Motil       Date:  2009-02-10       Impact factor: 2.698

9.  Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis.

Authors:  Jane S Titterington; Sergiy Sukhanov; Yusuke Higashi; Charlotte Vaughn; Cyril Bowers; Patrice Delafontaine
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

10.  Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase.

Authors:  Michael Backlund; Kirsi Paukku; Laurent Daviet; Rudolf A De Boer; Erkka Valo; Sampsa Hautaniemi; Nisse Kalkkinen; Afshin Ehsan; Kimmo K Kontula; Jukka Y A Lehtonen
Journal:  Nucleic Acids Res       Date:  2009-02-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.